CHARACTERISTIC OF MORTALITY IN PNEUMONIA CAUSED BY NEW CORONAVIRAL INFECTION
Abstract
Background. The true causes of mortality and risk factors for pneumonia caused by COVID-19 require detailed analysis.
Purpose: to clarify the risk factors for death in pneumonia caused by the SARS-CoV-2 virus.
Materials and methods. A total of 196 patients with pneumonia of coronavirus etiology were examined. The observation group consisted of 68 patients with a lethal outcome, the comparison group consisted of 128 patients discharged with improvement. The assessment of the significance of risk factors for death was carried out by determining the magnitude of the relative risk and the etiological fraction. The results of the study were subjected to statistical processing with the calculation of the mean values, errors of the mean values, the criterion of reliability of the Student’s indicators (t).
Results. The likelihood of death in patients with pneumonia caused by COVID-19 increases with increasing age of patients, living in the city, with prolonged persistence of febrile syndrome, the need for re-hospitalization and transfer to the intensive care unit, and a large amount of damage. Respiratory failure of the III degree, renal failure, pleurisy, toxic liver damage, hematomas of various localization increase the risk of death. The course of COVID-19 infection is aggravated by chronic heart failure, coronary heart disease, diabetes mellitus, and chronic obstructive pulmonary disease. Laboratory predictors of an unfavorable outcome are cytopenia (lymphopenia, thrombocytopenia, anemia), a significant increase in ESR, CRP, D-dimer.
Conclusion. Timely identification and consideration of risk factors for death will make it possible to adjust the volume of treatment measures in order to improve the prognosis for the life of patients with COVID-19-associated pneumonia.
Downloads
References
Shklyaev A.E., Kazarin D.D., Muravtseva O.V., Starodubtseva O.I. Analiz letal’nyh iskhodov ot pnevmonii v medicinskih organizaciyah Udmurtskoj Respubliki [Analysis of lethal outcomes from pneumonia in medical organizations of the Udmurt Republic]. Zdorov’e, demografiya, ekologiya finno-ugorskih narodov [Health, demography, ecology of the Finno-Ugric peoples], 2019, no. 3, pp. 5-9.
Bazykina E.A., Trotsenko O.E. Osobennosti pnevmonij, vyzvannyh novym koronavirusom SARS-COV-2 (obzor literatury) [Features of pneumonia caused by the new coronavirus SARS-COV-2 (literature review)]. Byulleten’ fiziologii i patologii dyhaniya [Bulletin of Respiratory Physiology and Pathology], 2020, no. 78, pp. 135-146. https://doi.org/10.36604/1998-5029-2020-78-135-146
Vremennye metodicheskie rekomendacii «Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19). Versiya 11 (07.05.2021)» [Interim guidelines “Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 11 (05/07/2021)”]. Moscow, 2021, 225 p. https://normativ.kontur.ru/document?moduleId=1&documentId=392173
Poteshkina N.G., Lysenko M.A., Kovalevskaya E.A., Fomina D.S., Samsonova I.V., Parshin V.V., Manchenko O.V., Evsyukov O.Yu. Kardial’noe povrezhdenie u pacientov s koronavirusnoj infekciej COVID-19 [Cardiac injury in patients with coronavirus infection COVID-19]. Arterial’naya gipertenziya [Arterial hypertension], 2020, no. 26(3), pp. 277-287. https://doi.org/10.18705/1607-419X-2020-26-3-277-287
Malinnikova E.Yu. Novaya koronavirusnaya infekciya. Segodnyashnij vzglyad na pandemiyu XXI veka [New coronavirus infection. Today’s look at the pandemic of the XXI century]. Infekcionnye bolezni: Novosti. Mneniya. Obuchenie. [Infectious Diseases: News. Opinions. Training.], 2020, vol. 9, no. 2(33), pp. 18-32. https://doi.org/10.33029/2305-3496-2020-9-2-18-32
Nikitin Yu.E., Nikitin E.N., Shklyaev A.E. Klinicheskoe znachenie gepcidina pri vnebol’nichnoj pnevmonii, oslozhnennoj anemiej [Clinical significance of hepcidin in community-acquired pneumonia complicated by anemia]. Prakticheskaya medicina [Practical Medicine], 2014, no. 3(79), pp. 162-167. http://pmarchive.ru/klinicheskoe-znachenie-gepcidina-pri-vnebolnichnoj-pnevmonii-oslozhnennoj-anemiej/
Osnovnye pokazateli zdorov’ya naseleniya i effektivnosti ispol’zovaniya resursov v sisteme zdravoohraneniya Udmurtskoj Respubliki za 2020 g. (po predvaritel’nym statisticheskim dannym) [Main indicators of population health and efficiency of resource use in the health care system of the Udmurt Republic for 2020 (according to preliminary statistics)]. Izhevsk, 2021, 43 p. http://rmiac.udmmed.ru/inform-analit_materialy/
Shklyaev A.E., Semenova M.V., Lyalina A.S., Maksimov I.Ye.Ocenka faktorov riska sverhrannih prezhdevremennyh rodov [Assessment of risk factors for very early preterm labor]. Vestnik Avicenny [Bulletin of Avicenna], 2019, no. 1, pp. 26-32. https://doi.org/10.25005/2074-0581-2019-21-1-26-32
Lobanova O.A., Trusova D.S., Rudenko E.E., Protsenko D.D., Kogan E.A. Patomorfologiya novoj koronavirusnoj infekcii COVID-19 [Pathomorphology of a new coronavirus infection COVID-19]. Sibirskij zhurnal klinicheskoj i eksperimental’noj mediciny [Siberian Journal of Clinical and Experimental Medicine], 2020, vol. 35, no. 3, pp. 47-52. https://doi.org/10.29001/2073-8552-2020-35-3-47-52
Romanov B.K. Koronavirusnaya infekciya covid-2019 [Coronavirus infection covid-2019]. Bezopasnost’ i risk farmakoterapii [Safety and risk of pharmacotherapy], 2020, vol. 8, no. 1, pp. 3-8. https://doi.org/10.30895/2312-7821-2020-8-1-3-8
Spravochnik po profilaktike i lecheniyu COVID-19 [Handbook for the prevention and treatment of COVID-19] / Ed. T. Liang. Hangzhou: Zhejiang University Press, 2020, 68 p. http://education.almazovcentre.ru/wp-content/uploads/2020/03/Spravochnik_po_profilaktike_i_lecheniju_COVID_19.pdf
Shklyaev A.E., Malakhova I.G., Gorbunov Yu.V., Kovarina Zh.A., Rachikhina A.N. Faktory riska letal’nogo iskhoda pri zabolevaniyah pecheni (retrospektivnyj i prospektivnyj analiz) [Risk factors for lethal outcome in liver diseases (retrospective and prospective analysis)]. Prakticheskaya medicina [Practical medicine], 2014, no. 1(77), pp. 74-77.
Shklyaev A.E., Malakhova I.G. Letal’nye iskhody ot patologii organov pishchevareniya v LPU Udmurtskoj Respubliki: analiz za 2005-2010 gody [Lethal outcomes from the pathology of the digestive system in the medical institution of the Udmurt Republic: analysis for 2005-2010]. Zdorov’e, demografiya, ekologiya finno-ugorskih narodov [Health, demography, ecology of the Finno-Ugric peoples], 2012, no. 1, pp. 33-36.
Shklyaev A.E., Malakhova I.G. Prognosticheskoe znachenie pokazatelej gemostaza pri zabolevaniyah pecheni [Prognostic value of hemostasis indices in liver diseases]. Tromboz, gemostaz i reologiya [Thrombosis, hemostasis and rheology], 2016, no. S3(67), pp. 462-464.
Pshenichnaya N.Yu., Lizinfeld I.A., Zhuravlev G.Yu., Ploskireva A.A., Akimkin V.G. Epidemicheskij process COVID-19 v Rossijskoj Federacii: promezhutochnye itogi. Soobshchenie 1. [Epidemic process of COVID-19 in the Russian Federation: interim results. Communication 1.]. Infekcionnye bolezni [Infectious diseases], 2020., no. 18(3), pp. 7-14. https://doi.org/10.20953/1729-9225-2020-3-7-14
Shchelkanov M.Yu., Kolobukhina L.V., Burgasova O.A., Kruzhkova I.S., Maleev V.V. COVID-19: etiologiya, klinika, lechenie [COVID-19: etiology, clinic, treatment]. Infekciya i immunitet [Infection and immunity], 2020, vol. 10, no. 3, pp. 421-445. https://doi.org/10.15789/2220-7619-CEC-1473
Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, vol. 395, pp. 507-513. https://doi.org/10.1016/S0140-6736(20)30211-7
Chen T., Wu D., Chen H., Yan W., Yang D., Chen G. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Br. Med. J., 2020, №1091 (March): m1091. https://doi.org/10.1136/bmj.m1091
Henderson L.A., Canna S.W., Schulert G.S., Volpi S., Lee P.Y., Kernan K.F. et al. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheum., 2020. https://doi.org/10.1002/art.41285
Porfidia A., Pola R. Venous thromboembolism in COVID-19 patients. J. Thromb. Haemost., 2020, vol. 18(6), pp. 1516-1517. https://doi.org/10.1111/jth.14842
Ryu S., Chun B.C. An interim review of the epidemiological characteristics of 2019 novel coronavirus. Epidemiol. Health., 2020, vol. 42: e2020006. https://doi.org/10.4178/epih.e2020006
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19). China: China CDC Weekly, 2020, vol. 2(8), pp. 113-22.
Wang L., He W., Yu X., Hu D., Bao M., Liu H. et al. Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J. Infection, 2020. https://doi.org/10.1016/j.jinf.2020.03.019
Copyright (c) 2021 Aleksey E. Shklyaev, Anastasia S Lyalina, Ayrat A. Khamadullin, Andrey V. Shabelnik, Stanislav V. Ilyin
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
